Publications by authors named "HM Ismail"

Inhibition of the adenosine 2A receptor (AR) is recognized as a promising immunotherapeutic strategy but is challenged by the ubiquity of AR function in the immune system. To develop a safe yet efficacious immunotherapy, the discovery of a novel negative allosteric modulator (NAM) was preferred. Leveraging an in-house, sensitive, high-throughput screening cellular assay, novel AR NAM scaffolds were identified, followed by an extensive structure-activity relationship (SAR) study, leading to the discovery of potent 2-amino-3,5-dicyanopyridine derivatives.

View Article and Find Full Text PDF

Indoor residual spraying (IRS) and the use of insecticide-treated bednets for malaria vector control have contributed substantially to a reduction in malaria disease burden. However, these control tools have important shortcomings including being donor-dependent, expensive, and often failing because of insufficient uptake. We assessed the safety and efficacy of a user-friendly, locally tailored malaria vector control approach dubbed "Hut Decoration for Malaria Control" (HD4MC) based on the incorporation of a WHO-approved insecticide, Actellic 300 CS, into a customary hut decoration practice in rural Uganda where millions of the most vulnerable and malaria-prone populations live in mud-walled huts.

View Article and Find Full Text PDF

Background/objectives: Vitamin K2 analogs are associated with decreased vascular calcification, which may provide protective benefits for individuals with coronary artery disease (CAD) by stimulating anti-calcific proteins like matrix Gla protein and adjusting innate immune responses. This study addresses a significant gap in understanding the association between serum levels of vitamin K2 analogs in different CAD types and examines their correlations with clinical risk parameters in CAD patients.

Methods: This case-control study enrolled CAD patients and healthy controls to assess and compare serum concentrations of two vitamin K2 analogs including menaquinone-4 (MK-4) and menaquinone-7 (MK-7) via ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated a glucose fraction that operates independently of insulin secretion in individuals positive for diabetes-related autoantibodies.
  • It utilized data from two major trials, analyzing the relationship between the glucose response and insulin levels through linear regression.
  • Findings revealed that this independent glucose fraction (iAUCGLU) significantly contributes to the rise in blood sugar levels in impaired glucose tolerance and is a stronger predictor for this condition than for type 1 diabetes (T1D).
View Article and Find Full Text PDF
Article Synopsis
  • Insulin resistance is an important factor in the early stages of type 1 diabetes (T1D) risk, and the study looks at its genetic, metabolic, and immune aspects among at-risk individuals.
  • Researchers divided relatives of T1D patients into high and low insulin resistance groups and assessed their genetic risk, glucose control, metabolic hormones, and immune cell profiles.
  • The high insulin resistance group showed metabolic changes like increased insulin levels and a unique immune cell profile with more insulin-specific CD8 T cells, suggesting a link between insulin resistance and immune responses in T1D susceptibility.
View Article and Find Full Text PDF

Background: Knockout (KO) ferrets with the cystic fibrosis transmembrane conductance regulator (CFTR) exhibit distinct phases of dysglycemia and pancreatic remodeling prior to cystic fibrosis-related diabetes (CFRD) development. Following normoglycemia during the first month of life (Phase l), hyperglycemia occurs during the subsequent 2 months (Phase Il) with decreased islet mass, followed by a period of near normoglycemia (Phase Ill) in which the islets regenerate. We aimed to characterize islet hormone expression patterns across these Phases.

View Article and Find Full Text PDF

Aims/hypothesis: We aimed to analyse TrialNet Anti-CD3 Prevention (TN10) data using oral minimal model (OMM)-derived indices to characterise the natural history of stage 2 type 1 diabetes in placebo-treated individuals, to describe early metabolic responses to teplizumab and to explore the predictive capacity of OMM measures for disease-free survival rate.

Methods: OMM-estimated insulin secretion, sensitivity and clearance and the disposition index were evaluated at baseline and at 3, 6 and 12 months post randomisation in placebo- and teplizumab-treated groups, and, within each group, in slow- and rapid-progressors (time to stage 3 disease >2 or 2 years). OMM metrics were also compared with the standard AUC C-peptide.

View Article and Find Full Text PDF
Article Synopsis
  • The study addressed the lack of data on skin fungal infections in Iraq, estimating their prevalence and burden for the first time.
  • It found approximately 985,628 serious fungal infections and over 2 million superficial infections annually, affecting a significant portion of the population.
  • Common infections included recurrent Candida vaginitis and fungal rhinosinusitis, with many estimates relying on data from other countries, highlighting the need for more localized research.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigated how adding zinc oxide and magnesium oxide nanoparticles to resin infiltrant affects microleakage in artificially induced carious lesions on bovine teeth.
  • Various groups were tested, with results showing that standard resin infiltrant completely prevented microleakage, while modified versions with nanoparticles also performed well but with some variation in effectiveness.
  • Significant differences were noted between the untreated carious lesions and the groups treated with resin infiltrant or its nanoparticle-modified versions, highlighting the effectiveness of the treatments.
View Article and Find Full Text PDF

Context: Obesity is prevalent in type 1 diabetes (T1D) and is problematic with higher risk for diabetes complications. It is unknown to what extent gut microbiome changes are associated with obesity and T1D.

Objective: This work aimed to describe the gut microbiome and microbial metabolite changes associated with obesity in T1D.

View Article and Find Full Text PDF

Insecticide-treated nets (ITNs) are the most effective method for malaria prevention in Africa. Using near-infrared video tracking in a laboratory environment, we recorded and assessed bednet entry and exit by a northern Tanzanian population of at a human-occupied untreated net and a PermaNet® 2.0 ITN.

View Article and Find Full Text PDF

Background: Orthodontic education, besides some other factors, influences the confidence level of recently graduated dentists to diagnose subjects seeking orthodontic treatment and provide treatment plans. This study aims to explore the factors that influence the confidence level of undergraduate dental students to diagnose subjects seeking orthodontic treatment and provide treatment plans after graduation.

Methods: A qualitative study was undertaken using focus groups and interviews.

View Article and Find Full Text PDF

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programs are being increasingly emphasized. Once broadly implemented, screening initiatives will identify significant numbers of islet autoantibody-positive (IAb+) children and adults who are at risk for (confirmed single IAb+) or living with (multiple IAb+) early-stage (stage 1 and stage 2) type 1 diabetes. These individuals will need monitoring for disease progression; much of this care will happen in nonspecialized settings.

View Article and Find Full Text PDF

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programmes are being increasingly emphasised. Once broadly implemented, screening initiatives will identify significant numbers of islet autoantibody-positive (IAb) children and adults who are at risk of (confirmed single IAb) or living with (multiple IAb) early-stage (stage 1 and stage 2) type 1 diabetes. These individuals will need monitoring for disease progression; much of this care will happen in non-specialised settings.

View Article and Find Full Text PDF

Duchenne muscular dystrophy (DMD) is the most common muscular disorder affecting children. It affects nearly 1 male birth over 5000. Oxidative stress is a pervasive feature in the pathogenesis of DMD.

View Article and Find Full Text PDF

Acetylated and butyrylated high amylose starch (HAMS-AB) is a prebiotic shown to be effective in type 1 diabetes (T1D) prevention in mouse models and is safe in adults with established T1D. HAMS-AB alters the gut microbiome profile with increased bacterial fermenters that produce short chain fatty acids (SCFAs) with anti-inflammatory and immune-modulatory effects. We performed a pilot study using a cross-over design to assess the safety and efficacy of 4 weeks of oral HAMS-AB consumption by recently diagnosed (< 2 years of diagnosis) youths with T1D.

View Article and Find Full Text PDF

Background: Medical students hold significant importance, as they represent the future of healthcare provision. This study aimed to explore psychological antecedents towards the monkeypox (mpox) vaccines among postgraduate and undergraduate medical students across countries.

Methods: A cross-sectional survey was conducted among medical students aged 18 years old and above in 7 countries; Egypt, Romania, Malaysia, and Yemen, Iraq, India, and Nigeria.

View Article and Find Full Text PDF

Objective: Mixed-meal tolerance test-stimulated area under the curve (AUC) C-peptide at 12-24 months represents the primary end point for nearly all intervention trials seeking to preserve β-cell function in recent-onset type 1 diabetes. We hypothesized that participant benefit might be detected earlier and predict outcomes at 12 months posttherapy. Such findings would support shorter trials to establish initial efficacy.

View Article and Find Full Text PDF
Article Synopsis
  • Islet autoantibodies are crucial for diagnosing and understanding the variability in type 1 diabetes (T1D) progression and response to treatments.
  • A review of 152 studies indicated that the majority focused on autoantibody characteristics before T1D diagnosis, highlighting correlations between autoantibody types, numbers, and disease progression.
  • The findings emphasize the need for precise definitions of T1D based on autoantibodies and suggest improving research methods through standardization to enhance the effectiveness of precision medicine in T1D.
View Article and Find Full Text PDF

Context: Metabolic measures are frequently used to predict type 1 diabetes (T1D) and to understand effects of disease-modifying therapies.

Objective: Compare metabolic endpoints for their ability to detect preventive treatment effects and predict T1D.

Methods: Six-month changes in metabolic endpoints were assessed for (1) detecting treatment effects by comparing placebo and treatment arms from the randomized controlled teplizumab prevention trial, a multicenter clinical trial investigating 14-day intravenous teplizumab infusion and (2) predicting T1D in the TrialNet Pathway to Prevention natural history study.

View Article and Find Full Text PDF

Traditional electrospinning is a promising technique for fabricating nanofibers for tissue engineering and drug delivery applications. The method is highly efficient in producing nanofibers with morphology and porosity similar to the extracellular matrix. Nonetheless, and in many instances, the process has faced several limitations, including weak mechanical strength, large diameter distributions, and scaling-up difficulties of its fabricated electrospun nanofibers.

View Article and Find Full Text PDF

Unlabelled: Obesity is increasingly prevalent in type 1 diabetes (T1D) and is associated with management problems and higher risk for diabetes complications. Gut microbiome changes have been described separately in each of T1D and obesity, however, it is unknown to what extent gut microbiome changes are seen when obesity and T1D concomitantly occur.

Objective: To describe the gut microbiome and microbial metabolite changes associated with obesity in T1D.

View Article and Find Full Text PDF